Summary
The absorption of acetylsalicylic acid (ASA) from two different enteric-coated dosage forms, tablets (Premaspin) and granules (Reumyl®), was studied in healthy volunteers under fasting and non-fasting conditions by following the plasma concentration and urine recovery of salicylates after single doses of ASA 1 g. Conventional tablets (Aspirin®) were used as the reference. Under fasting conditions the absorption of ASA from the two different enteric-coated preparations was complete. Taken with food the enteric-coated tablets gave much lower plasma concentrations than under fasting conditions, and absorption was not complete in all subjects. In contrast, absorption from the enteric-coated granules was not influenced by the intake of food. It was concluded that enteric-coated granules of ASA permit more reproducible absorption than enteric-coated tablets.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arvidsson, B., Magnusson, A., Magnusson, B., Sölvell, L.: Acetylsalicylsyra och gastrointestinal blödning — en studie av blodförlust och absorption efter intag av ett magsaftresistent preparat. Läkartidningen74, 4101–4102 (1977)
Blythe, R. H., Grass, G. M., MacDonnell, D. R.: The formulation and evaluation of enteric coated aspirin tablets. Am. J. Pharmacol.131, 206–216 (1959)
Clark, R. L., Lasagna, L.: How reliable are enteric-coated aspirin preparations? Clin. Pharmacol. Ther.6, 568–574 (1965)
Croft, D. N., Wood, P. H. N.: Gastric mucosa and susceptibility to occult gastrointestinal bleeding caused by aspirin. Br. med. J.1967/I, 137–141
Day, R. O., Paul, P. D., Champion, G. D., Graham, G. G.: Evaluation of an enteric coated aspirin preparation. Aust. N. Z. J. Med.6, 45–50 (1976)
Edmar, D.: The effects of acetylsalicylic acid on the human gastric mucosa as revealed by gastrocamera. Scand. J. Gastroenterol.10, 495–499 (1975)
Green, D. M.: Tablets of coated aspirin microspherules — a new dosage form. J. New Drugs6, 294–304 (1966)
Halvorsen, L., Dotevall, G., Sevelius, H.: Comparative effects of aspirin and naproxen on gastric mucosa. Scand. J. Rheumatol. 43, Suppl.2, 43–47 (1973)
Leonards, J. R., Levy, G.: Absorption and metabolism of aspirin administered in enteric-coated tablets. J. Amer. Med. Ass.193, 99–104 (1965)
Levy, G., Prochnal, J. A.: Drug biotransformation interactions in man. I. Mutual inhibition in glucoronide formation of salicylic acid and salicylonid in man. J. Pharm. Sci.57, 1330–1335 (1968)
Merenda, S. J., Green, D. M.: X-ray evaluation of tablet distintegration and gastric passage. Pharmacologist8, 180 (1966)
Paull, P., Day, R., Graham, G., Champion, D.: Single-dose evaluation of a new enteric-coated aspirin preparation. Med. J. Aust.1, 617–619 (1976)
Pierson, R. N., Holt, P. R., Watson, R. M., Keating, R. P.: Aspirin and gastrointestinal bleeding. Am. J. Med.31, 295–265 (1961)
Scott, J. T., Porter, I. H., Lewis, S. M., Dixon, A. St. J.: Studies of gastrointestinal bleeding caused by corticosteroids, salicylates, and other analgetics. Q.J. Med.30, 167–188 (1961)
Stubbé, L. Th. F. L., Pietersen, J. H.: van Heulen, C.: Aspirin preparations and their noxious effect on the gastrointestinal tract. Br. med. J.1962/II 675–680
Thorsen, W. B., Western, D., Tanaka, Y., Morrissey, J. F.: Aspirin injury to the gastric mucosa. Gastrocamera observations of the effect of pH. Arch. intern. Med.121, 499–506 (1968)
Tikkanen, R., Strandman, D.: Cellulose acetate biphtalate, CAP, as enteric coating material. The absorption of acetylsalicylic acid from the CAP coated enteric tablets. Farmaceut. Notisblad74, 59–72 (1965)
Wagner, J. G.: Enteric coatings. In: Biopharmaceutics and relevant pharmacokinetics. Drug intelligence publications pp. 158–165. Hamilton, Illinois: Hamilton Press 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bogentoft, C., Carlsson, I., Ekenved, G. et al. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms. Eur J Clin Pharmacol 14, 351–355 (1978). https://doi.org/10.1007/BF00611905
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00611905